Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 19587.62 | 1809 / 1809 | 94% | 103.55 | 445 / 472 |
ovary | 98% | 9271.22 | 177 / 180 | 93% | 85.05 | 398 / 430 |
esophagus | 92% | 6212.36 | 1330 / 1445 | 98% | 110.10 | 179 / 183 |
breast | 100% | 12142.51 | 459 / 459 | 88% | 69.45 | 980 / 1118 |
intestine | 87% | 5294.17 | 836 / 966 | 98% | 154.53 | 516 / 527 |
stomach | 82% | 5792.94 | 294 / 359 | 98% | 139.77 | 280 / 286 |
pancreas | 90% | 4500.89 | 296 / 328 | 88% | 44.54 | 157 / 178 |
uterus | 92% | 4835.37 | 156 / 170 | 84% | 76.57 | 384 / 459 |
lung | 85% | 4643.33 | 491 / 578 | 90% | 72.07 | 1038 / 1155 |
prostate | 76% | 3181.53 | 187 / 245 | 95% | 74.89 | 475 / 502 |
bladder | 90% | 4637.76 | 19 / 21 | 80% | 90.59 | 402 / 504 |
adrenal gland | 97% | 4381.14 | 249 / 258 | 30% | 12.32 | 69 / 230 |
kidney | 31% | 1217.29 | 28 / 89 | 79% | 50.62 | 715 / 901 |
thymus | 74% | 2605.52 | 482 / 653 | 32% | 17.16 | 194 / 605 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.50 | 1 / 1 |
adipose | 100% | 16849.26 | 1203 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 134.17 | 79 / 80 |
spleen | 98% | 6374.12 | 237 / 241 | 0% | 0 | 0 / 0 |
liver | 41% | 1635.79 | 93 / 226 | 57% | 25.98 | 230 / 406 |
tonsil | 0% | 0 | 0 / 0 | 96% | 89.82 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 68.08 | 27 / 29 |
brain | 0% | 10.03 | 13 / 2642 | 80% | 36.71 | 563 / 705 |
blood vessel | 69% | 3722.82 | 921 / 1335 | 0% | 0 | 0 / 0 |
muscle | 58% | 2531.28 | 463 / 803 | 0% | 0 | 0 / 0 |
heart | 52% | 2174.53 | 451 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 40% | 3949.19 | 372 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010468 | Biological process | regulation of gene expression |
GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
GO_0090096 | Biological process | positive regulation of metanephric cap mesenchymal cell proliferation |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
GO_0048147 | Biological process | negative regulation of fibroblast proliferation |
GO_0032204 | Biological process | regulation of telomere maintenance |
GO_0000165 | Biological process | MAPK cascade |
GO_0034644 | Biological process | cellular response to UV |
GO_1904672 | Biological process | regulation of somatic stem cell population maintenance |
GO_0010332 | Biological process | response to gamma radiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0006974 | Biological process | DNA damage response |
GO_0051782 | Biological process | negative regulation of cell division |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_1902255 | Biological process | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
GO_0044027 | Biological process | negative regulation of gene expression via chromosomal CpG island methylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0032873 | Biological process | negative regulation of stress-activated MAPK cascade |
GO_0002053 | Biological process | positive regulation of mesenchymal cell proliferation |
GO_0060633 | Biological process | negative regulation of transcription initiation by RNA polymerase II |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_0051276 | Biological process | chromosome organization |
GO_0010564 | Biological process | regulation of cell cycle process |
GO_0045656 | Biological process | negative regulation of monocyte differentiation |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0051973 | Biological process | positive regulation of telomerase activity |
GO_0032986 | Biological process | protein-DNA complex disassembly |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0044346 | Biological process | fibroblast apoptotic process |
GO_0070848 | Biological process | response to growth factor |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090571 | Cellular component | RNA polymerase II transcription repressor complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0071943 | Cellular component | Myc-Max complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001046 | Molecular function | core promoter sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0001221 | Molecular function | transcription coregulator binding |
GO_0042802 | Molecular function | identical protein binding |
GO_1905761 | Molecular function | SCF ubiquitin ligase complex binding |
GO_0070888 | Molecular function | E-box binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MYC |
Protein name | Myc proto-oncogene protein (Proto-oncogene c-Myc) (Transcription factor p64) Myc protein MYC proto-oncogene, bHLH transcription factor (Myc-related translation/localization regulatory factor) (ORF 114) MYC proto-oncogene, bHLH transcription factor (Myc protein) (ORF 118) MYC proto-oncogene, bHLH transcription factor C-myc protein MYC proto-oncogene, bHLH transcription factor (V-myc myelocytomatosis viral oncogene homolog (Avian), isoform CRA_b) Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39) (bHLHe39) (Proto-oncogene c-Myc) (Transcription factor p64) V-myc myelocytomatosis viral oncogene homolog |
Synonyms | BHLHE39 hCG_15917 MRTL |
Description | FUNCTION: Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3' . Activates the transcription of growth-related genes . Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis . Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells (By similarity). Functions with TAF6L to activate target gene expression through RNA polymerase II pause release (By similarity). Positively regulates transcription of HNRNPA1, HNRNPA2 and PTBP1 which in turn regulate splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform . . |
Accessions | B3CJB8 B3CJD6 ENST00000652288.1 [P01106-1] B3CJ72 B3CJC0 ENST00000707115.1 [P01106-1] Q14899 B3CJ63 B3CJA7 B3CJB9 B3CJC7 B3CJE0 B0B0N9 H0YBG3 ENST00000707114.1 [P01106-1] B3CJ93 B3CJA3 A0A494C1T8 B3CJ94 B3CJ78 B3CJD3 B3CJ74 B3CJ73 B3CJD8 B3CJB3 B3CJC6 B3CJ77 B3CJB1 ENST00000259523.10 B3CJD5 ENST00000707113.1 [P01106-1] B3CJ66 B3CJ89 ENST00000377970.6 [P01106-1] B3CJ90 B3CJ75 B3CJ65 B3CJ64 B3CJ88 B3CJ69 B3CJC8 B3CJD2 Q16591 B3CJ82 B3CJB0 B3CJB2 B3CJ92 ENST00000524013.2 [P01106-3] B3CJ81 B3CJD7 B3CJA8 B3CJ76 B3CJ91 B3CJA4 P01106 ENST00000621592.8 [P01106-2] A0A0B4J1R1 ENST00000641036.1 B3CJD1 B3CJ86 ENST00000641252.1 B3CJ87 B3CJD9 Q14901 B3CJA9 B3CJ71 ENST00000517291.2 B3CJA1 ENST00000707116.1 [P01106-1] ENST00000651626.1 A0A224B085 A0N2G3 |